REstoration of VItamin D in Pulmonary Arterial Hypertension

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 102 participants.

Also called NCT06258850

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 102 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06258850
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT06258850. Randomized; quadruple masking; primary purpose treatment. Start 2024-07-01 (anticipated); primary completion 2027-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
REstoration of VItamin D in Pulmonary Arterial Hypertension
Acronym
REVIDAH
Condition
Pulmonary Artery Hypertension
Condition
Vitamin d Deficiency
Intervention (Drug)
Calcifediol Oral Capsule
Intervention (Drug)
Placebo
Lead sponsor
Parc de Salut Mar (class: other)
Collaborator
Universidad Complutense de Madrid (class: other)
Collaborator
Hospital Clinic of Barcelona (class: other)
Collaborator
Hospital Vall d'Hebron (class: other)
Collaborator
Hospital Universitario Marqués de Valdecilla (class: other)
Collaborator
Hospital Universitario de Gran Canaria Doctor Negrín (class: other)
Collaborator
Hospital Universitario La Fe (class: other)
Collaborator
Hospital Universitario Doctor Peset (class: other)
Collaborator
Hospital Universitario Ramon y Cajal (class: other)
Collaborator
Hospitales Universitarios Virgen del Rocío (class: other)

Record details

Record id
cardio:ct-nct06258850
Content hash
212c8d4b5494147b5ceca2c43b188db7ce3c614def46b8b6618bebb345526106